DiaMedica Therapeutics (DMAC) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $7.57, -5.85% vs the prior close of $8.04.
- Volume 260.78K shares, 1.4x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
DMAC slides 5.8% to $7.57. Closed at $7.57, -5.85% vs the prior close of $8.04. Day range $7.55–$8.10, opened at $8.04.
DMAC daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — DMAC slides 5.8% to $7.57
- Closed at $7.57, -5.85% vs the prior close of $8.04. Day range $7.55–$8.10, opened at $8.04.
- Volume was 260.78K shares, 1.4x its 50-day average of 182.63K.
- Price is +5.4% vs its 50-day average ($7.18) and +6.9% vs its 200-day average ($7.08).
- 52-week range $5.24–$10.42; today's close sits at 45% of that range, 27.3% below the 52-week high.
Oct 15, 2026 — DMAC jumps 5.0% to $8.04
- Closed at $8.04, +4.96% vs the prior close of $7.66. Day range $7.66–$8.24, opened at $7.82.
- Volume was 303.90K shares, 1.7x its 50-day average of 179.16K.
- Price is +12.2% vs its 50-day average ($7.16) and +13.5% vs its 200-day average ($7.08).
- 52-week range $5.24–$10.42; today's close sits at 54% of that range, 22.8% below the 52-week high.
Oct 14, 2026 — DMAC dips 2.0% to $7.66, 3 down days in a row
- Closed at $7.66, -2.05% vs the prior close of $7.82. Day range $7.61–$8.02, opened at $7.68.
- Volume was 287.00K shares, 1.6x its 50-day average of 176.68K.
- Price is +7.3% vs its 50-day average ($7.14) and +8.1% vs its 200-day average ($7.08).
- 52-week range $5.24–$10.42; today's close sits at 47% of that range, 26.5% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — DMAC slides 4.6% to $7.82
- Closed at $7.82, -4.63% vs the prior close of $8.20. Day range $7.72–$8.21, opened at $8.21.
- Volume was 256.00K shares, 1.5x its 50-day average of 175.00K.
- Price is +9.9% vs its 50-day average ($7.11) and +10.3% vs its 200-day average ($7.09).
- 52-week range $5.24–$10.42; today's close sits at 50% of that range, 24.9% below the 52-week high.
Oct 12, 2026 — DMAC dips 1.6% to $8.20
- Closed at $8.20, -1.56% vs the prior close of $8.33. Day range $7.95–$8.34, opened at $8.26.
- Volume was 185.60K shares, 1.1x its 50-day average of 173.26K.
- Price is +15.7% vs its 50-day average ($7.09) and +15.6% vs its 200-day average ($7.09).
- 52-week range $5.24–$10.42; today's close sits at 57% of that range, 21.3% below the 52-week high.
Oct 9, 2026 — DMAC jumps 4.0% to $8.33
- Closed at $8.33, +4.00% vs the prior close of $8.01. Day range $8.00–$8.45, opened at $8.00.
- Volume was 170.20K shares, 1.0x its 50-day average of 175.88K.
- Price is +18.2% vs its 50-day average ($7.05) and +17.5% vs its 200-day average ($7.09).
- 52-week range $5.24–$10.42; today's close sits at 60% of that range, 20.1% below the 52-week high.
Oct 8, 2026 — DMAC ends flat (+0.3%) to $8.01
- Closed at $8.01, +0.25% vs the prior close of $7.99. Day range $7.66–$8.06, opened at $7.92.
- Volume was 240.30K shares, 1.4x its 50-day average of 176.74K.
- Price is +14.2% vs its 50-day average ($7.01) and +12.9% vs its 200-day average ($7.09).
- 52-week range $5.24–$10.42; today's close sits at 53% of that range, 23.1% below the 52-week high.
Oct 7, 2026 — DMAC dips 1.7% to $7.99
- Closed at $7.99, -1.72% vs the prior close of $8.13. Day range $7.95–$8.41, opened at $8.01.
- Volume was 221.20K shares, 1.3x its 50-day average of 176.45K.
- Price is +14.5% vs its 50-day average ($6.98) and +12.6% vs its 200-day average ($7.09).
- 52-week range $5.24–$10.42; today's close sits at 53% of that range, 23.3% below the 52-week high.
Oct 6, 2026 — DMAC slides 3.4% to $8.13
- Closed at $8.13, -3.44% vs the prior close of $8.42. Day range $8.05–$8.61, opened at $8.50.
- Volume was 242.30K shares, 1.4x its 50-day average of 173.40K.
- Price is +16.9% vs its 50-day average ($6.95) and +14.6% vs its 200-day average ($7.10).
- 52-week range $5.24–$10.42; today's close sits at 56% of that range, 22.0% below the 52-week high.
Oct 5, 2026 — DMAC rises 2.3% to $8.42, a 6-month high
- Closed at $8.42, +2.31% vs the prior close of $8.23. Day range $8.19–$8.63, opened at $8.23.
- Volume was 231.40K shares, 1.3x its 50-day average of 172.31K.
- Price is +21.6% vs its 50-day average ($6.93) and +18.6% vs its 200-day average ($7.10).
- 52-week range $5.24–$10.42; today's close sits at 61% of that range, 19.2% below the 52-week high.
Oct 2, 2026 — DMAC dips 1.4% to $8.23 on 2.0x normal volume
- Closed at $8.23, -1.44% vs the prior close of $8.35. Day range $8.02–$8.61, opened at $8.49.
- Volume was 335.70K shares, 2.0x its 50-day average of 169.00K — unusually heavy trading.
- Price is +19.4% vs its 50-day average ($6.89) and +15.9% vs its 200-day average ($7.10).
- 52-week range $5.24–$10.42; today's close sits at 58% of that range, 21.0% below the 52-week high.
DMAC latest news & SEC filings
Every SEC filing by or about DMAC in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 12, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 11, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 10, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$10.14M (prior year -$7.70M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.19 (prior year -$0.18) (loss widened vs Jun 30, 2025)
Aug 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade DMAC
- Last results release: Aug 10, 2026 (8-K Item 2.02). Previous ones: May 6, 2026, Mar 31, 2026, Nov 12, 2025. Based on that rhythm, the next report is likely around Nov 9, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.06% (largest 7.2%). That is a volatile stock.
- Liquidity: about 249.76K shares (≈$1.89M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $7.57 vs a range of $5.24–$10.42 (45% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Ab Trill bought 73,099 shares on Nov 25, 2025.
- Latest filings: 10-Q Aug 10, 2026; 8-K Aug 10, 2026; 8-K May 21, 2026.
- Share count: 53.93M shares outstanding (Aug 3, 2026), +4.3% vs a year earlier.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
DMAC market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 8.04 | 8.10 | 7.55 | 7.57 | 260.78K |
| Oct 15, 2026 | 7.82 | 8.24 | 7.66 | 8.04 | 303.90K |
| Oct 14, 2026 | 7.68 | 8.02 | 7.61 | 7.66 | 287.00K |
| Oct 13, 2026 | 8.21 | 8.21 | 7.72 | 7.82 | 256.00K |
| Oct 12, 2026 | 8.26 | 8.34 | 7.95 | 8.20 | 185.60K |
| Oct 9, 2026 | 8.00 | 8.45 | 8.00 | 8.33 | 170.20K |
| Oct 8, 2026 | 7.92 | 8.06 | 7.66 | 8.01 | 240.30K |
| Oct 7, 2026 | 8.01 | 8.41 | 7.95 | 7.99 | 221.20K |
| Oct 6, 2026 | 8.50 | 8.61 | 8.05 | 8.13 | 242.30K |
| Oct 5, 2026 | 8.23 | 8.63 | 8.19 | 8.42 | 231.40K |
| Oct 2, 2026 | 8.49 | 8.61 | 8.02 | 8.23 | 335.70K |
| Oct 1, 2026 | 8.33 | 8.54 | 8.10 | 8.35 | 234.20K |
| Sep 30, 2026 | 8.27 | 8.60 | 8.19 | 8.27 | 219.10K |
| Sep 29, 2026 | 8.30 | 8.38 | 8.03 | 8.20 | 231.10K |
| Sep 28, 2026 | 7.86 | 8.55 | 7.79 | 8.32 | 362.80K |
| Sep 25, 2026 | 7.85 | 8.00 | 7.44 | 7.94 | 236.40K |
| Sep 24, 2026 | 7.57 | 7.89 | 7.43 | 7.83 | 209.20K |
| Sep 23, 2026 | 7.70 | 7.75 | 7.34 | 7.56 | 174.10K |
| Sep 22, 2026 | 7.34 | 7.80 | 7.30 | 7.78 | 312.10K |
| Sep 21, 2026 | 6.86 | 7.35 | 6.82 | 7.26 | 281.80K |
About DiaMedica Therapeutics
DiaMedica Therapeutics (DMAC) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in MINNEAPOLIS, MN. State of incorporation: Canada (Federal Level). Fiscal year ends December 31. SEC CIK 1401040.
DMAC board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Randall Michael Giuffre | Director | Jun 3, 2026 |
| Richard Kuntz | Director | Jun 3, 2026 |
| Tanya Lewis | Director | Jun 3, 2026 |
| Daniel J. O'Connor | Director | Jun 3, 2026 |
| James T. Parsons | Director | Jun 3, 2026 |
| Dietrich John Pauls | President & CEO | Aug 12, 2026 |
| Charles Pauling Semba | Director | Jun 3, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Scott Kellen | CFO & Secretary | Jun 3, 2026 |
| Julie Krop | Chief Medical Officer | Jun 3, 2026 |
| Dietrich John Pauls | President & CEO | Aug 12, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Nov 25, 2025 | Ab Trill | Buy | 73,099 | $8.57 |
| Nov 25, 2025 | Ab Trill | Buy | 73,099 | $8.57 |
| Nov 25, 2025 | Jan Stahlberg | Buy | 73,099 | $8.57 |
| Nov 25, 2025 | Jan Stahlberg | Buy | 73,099 | $8.57 |
| Nov 25, 2025 | Ab Trill | Buy | 73,099 | $8.57 |
| Nov 25, 2025 | Ab Trill | Buy | 73,099 | $8.57 |
| Nov 25, 2025 | Jan Stahlberg | Buy | 73,099 | $8.57 |
| Nov 25, 2025 | Jan Stahlberg | Buy | 73,099 | $8.57 |
| Nov 24, 2025 | Ab Trill | Buy | 40,253 | $7.89 |
| Nov 24, 2025 | Ab Trill | Buy | 40,253 | $7.89 |
| Nov 24, 2025 | Jan Stahlberg | Buy | 40,253 | $7.89 |
| Nov 24, 2025 | Jan Stahlberg | Buy | 40,253 | $7.89 |
| Nov 24, 2025 | Ab Trill | Buy | 40,253 | $7.89 |
| Nov 24, 2025 | Ab Trill | Buy | 40,253 | $7.89 |
| Nov 24, 2025 | Jan Stahlberg | Buy | 40,253 | $7.89 |
DMAC financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-32.77M | -0.70 | $-29.06M |
| Dec 31, 2024 | — | $-24.44M | -0.60 | $-22.08M |
| Dec 31, 2023 | — | $-19.38M | -0.60 | $-18.73M |
| Dec 31, 2022 | — | $-13.68M | -0.52 | $-11.51M |
| Dec 31, 2021 | — | $-13.59M | -0.65 | $-12.25M |
Latest balance sheet: total assets $45.00M, total liabilities $—, cash $5.13M (as of Jun 30, 2026).
DMAC earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 10, 2026 | 8-K Item 2.02 (results) | $6.65 |
| May 6, 2026 | 8-K Item 2.02 (results) | $6.52 |
| Mar 31, 2026 | 8-K Item 2.02 (results) | $6.77 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $6.31 |
| Aug 12, 2025 | 8-K Item 2.02 (results) | $5.22 |
| May 13, 2025 | 8-K Item 2.02 (results) | $3.98 |
| Mar 17, 2025 | 8-K Item 2.02 (results) | $5.99 |
| Nov 13, 2024 | 8-K Item 2.02 (results) | $4.26 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
| May 8, 2024 | 8-K Item 2.02 (results) | — |
| Mar 19, 2024 | 8-K Item 2.02 (results) | — |
| Nov 13, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on DMAC
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.